{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:27:28Z","timestamp":1783736848628,"version":"3.55.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Department of Biotechnology, Ministry of Science and Technology","award":["6242P33\/RGCB\/PMD\/DBT\/RPDH\/2015"],"award-info":[{"award-number":["6242P33\/RGCB\/PMD\/DBT\/RPDH\/2015"]}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["EMR\/2015\/000063"],"award-info":[{"award-number":["EMR\/2015\/000063"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,12]]},"DOI":"10.1093\/carcin\/bgy135","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T21:03:08Z","timestamp":1539205388000},"page":"173-183","source":"Crossref","is-referenced-by-count":45,"title":["STAT3- and GSK3\u03b2-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma"],"prefix":"10.1093","volume":"40","author":[{"given":"Santanu","family":"Maji","sequence":"first","affiliation":[{"name":"Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Odisha, India"},{"name":"Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omprakash","family":"Shriwas","sequence":"additional","affiliation":[{"name":"Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Odisha, India"},{"name":"Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabindra K","family":"Samal","sequence":"additional","affiliation":[{"name":"Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Odisha, India"},{"name":"Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manashi","family":"Priyadarshini","sequence":"additional","affiliation":[{"name":"Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Rath","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology and Microbiology, SCB Dental College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Panda","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, Odisha, India"},{"name":"HCG Panda Cancer Centre, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj Kumar","family":"Das Majumdar","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillip Kumar","family":"Muduly","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-7053","authenticated-orcid":false,"given":"Rupesh","family":"Dash","sequence":"additional","affiliation":[{"name":"Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"key":"key\n\t\t\t\t2019031204164339400_CIT0001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.oraloncology.2008.05.017","article-title":"Current concepts in management of oral cancer\u2013surgery","volume":"45","author":"Shah","year":"2009","journal-title":"Oral Oncol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0002","first-page":"25","article-title":"Molecular mechanisms of chemoresistance in oral cancer","volume":"19","author":"Wang","year":"2016","journal-title":"Chin. J. Dent. Res"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0003","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.4317\/medoral.18772","article-title":"Oral cancer: current role of radiotherapy and chemotherapy","volume":"18","author":"Huang","year":"2013","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1470-2045(10)70279-5","article-title":"Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial","volume":"12","author":"Lorch","year":"2011","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0971-5851.166716","article-title":"Neoadjuvant chemotherapy in oral cancers: selecting the right patients","volume":"36","author":"Vishak","year":"2015","journal-title":"Indian J. Med. Paediatr. Oncol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0006","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/13543784.2011.609167","article-title":"Targeting Mcl-1 for the therapy of cancer","volume":"20","author":"Quinn","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0008","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-10-0563","article-title":"Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7\/IL-24, an IL-10-related cytokine","volume":"70","author":"Dash","year":"2010","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0009","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2005.09.010","article-title":"Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy","volume":"44","author":"Sieghart","year":"2006","journal-title":"J. Hepatol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0010","doi-asserted-by":"crossref","first-page":"16623","DOI":"10.18632\/oncotarget.3932","article-title":"Mcl-1 is an important therapeutic target for oral squamous cell carcinomas","volume":"6","author":"Maji","year":"2015","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0011","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0012","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/onc.2010.559","article-title":"Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0013","first-page":"1325","article-title":"Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB","volume":"30","author":"Negoro","year":"2007","journal-title":"Int. J. Oncol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0014","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1423s60","article-title":"Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine","author":"DeRose","year":"2013","journal-title":"Curr. Protoc. Pharmacol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ncb1173","article-title":"Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition","volume":"6","author":"Zhou","year":"2004","journal-title":"Nat. Cell Biol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0016","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1073\/pnas.91.11.4806","article-title":"Stat3 and Stat4: members of the family of signal transducers and activators of transcription","volume":"91","author":"Zhong","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aam7049","article-title":"Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer","volume":"9","author":"Merino","year":"2017","journal-title":"Sci. Transl. Med"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0018","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1038\/srep09982","article-title":"Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer","volume":"5","author":"Samal","year":"2015","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0019","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12885-018-4528-x","article-title":"Estrogen receptor \u03b1 dependent regulation of estrogen related receptor \u03b2 and its role in cell cycle in breast cancer","volume":"18","author":"Madhu Krishna","year":"2018","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.acr.2017.11.001","article-title":"Bcl-2 antiapoptotic family proteins and chemoresistance in cancer","volume":"137","author":"Maji","year":"2018","journal-title":"Adv. Cancer Res"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0021","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.20966","article-title":"Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells","volume":"42","author":"Isomoto","year":"2005","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0022","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1128\/MCB.01266-09","article-title":"Ubiquitin-independent degradation of antiapoptotic MCL-1","volume":"30","author":"Stewart","year":"2010","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0023","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/MCB.00620-06","article-title":"Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization","volume":"27","author":"Ding","year":"2007","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0024","doi-asserted-by":"crossref","first-page":"33067","DOI":"10.1074\/jbc.M212635200","article-title":"Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nchembio.453","article-title":"Small-molecule inhibition of Wnt signaling through activation of casein kinase 1\u03b1","volume":"6","author":"Thorne","year":"2010","journal-title":"Nat. Chem. Biol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0026","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/cdd.2015.50","article-title":"The BCL-2 protein family, BH3-mimetics and cancer therapy","volume":"22","author":"Delbridge","year":"2015","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0027","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrc.2015.17","article-title":"Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies","volume":"16","author":"Delbridge","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0028","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.02.028","article-title":"Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency","volume":"21","author":"Wei","year":"2012","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0029","doi-asserted-by":"crossref","first-page":"59950","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0030","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0031","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/14728222.2013.733001","article-title":"Targeting the Bcl-2 family for cancer therapy","volume":"17","author":"Thomas","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0032","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"van Delft","year":"2006","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0033","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nchembio.391","article-title":"The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer","volume":"6","author":"Stewart","year":"2010","journal-title":"Nat. Chem. Biol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0034","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1021\/ja306864v","article-title":"Rational design of proteolytically stable, cell-permeable peptide-based selective Mcl-1 inhibitors","volume":"134","author":"Muppidi","year":"2012","journal-title":"J. Am. Chem. Soc"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0035","first-page":"3527","article-title":"The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1","volume":"8","author":"Gojo","year":"2002","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0036","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1158\/0008-5472.CAN-05-0233","article-title":"Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1","volume":"65","author":"MacCallum","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0037","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/jm1001265","article-title":"BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma\/leukemia-2 (Bcl-2) family proteins","volume":"53","author":"Wei","year":"2010","journal-title":"J. Med. Chem"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0038","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/ncomms16078","article-title":"Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy","volume":"8","author":"Inoue-Yamauchi","year":"2017","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0039","doi-asserted-by":"crossref","first-page":"156ra139","DOI":"10.1126\/scitranslmed.3004334","article-title":"A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Chugh","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.canlet.2013.02.050","article-title":"Minnelide reduces tumor burden in preclinical models of osteosarcoma","volume":"335","author":"Banerjee","year":"2013","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0041","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.oraloncology.2014.09.013","article-title":"Wild-type p53 reactivation by small-molecule Minnelide\u2122 in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma","volume":"50","author":"Caicedo-Granados","year":"2014","journal-title":"Oral Oncol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0042","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0043","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1476-4598-10-44","article-title":"Role of bile salt in regulating Mcl-1 phosphorylation and chemoresistance in hepatocellular carcinoma cells","volume":"10","author":"Liao","year":"2011","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0044","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00280-008-0697-7","article-title":"Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell","volume":"62","author":"Wei","year":"2008","journal-title":"Cancer Chemother. Pharmacol"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0045","doi-asserted-by":"crossref","first-page":"82981","DOI":"10.18632\/oncotarget.20222","article-title":"Mcl-1 stabilization confers resistance to Taxol in human gastric cancer","volume":"8","author":"Shuang","year":"2017","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t2019031204164339400_CIT0046","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10120-012-0153-6","article-title":"Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells","volume":"16","author":"Akagi","year":"2013","journal-title":"Gastric Cancer"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/40\/1\/173\/28044524\/bgy135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T18:57:03Z","timestamp":1605207423000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/40\/1\/173\/5159576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,11,3]]},"published-print":{"date-parts":[[2019,3,12]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgy135","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,11,3]]}}}